Viewing Study NCT06868433


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-02-08 @ 5:36 PM
Study NCT ID: NCT06868433
Status: RECRUITING
Last Update Posted: 2025-08-19
First Post: 2025-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 View
None Metastatic Head and Neck Squamous Cell Carcinoma View
None Metastatic Hypopharyngeal Squamous Cell Carcinoma View
None Metastatic Laryngeal Squamous Cell Carcinoma View
None Metastatic Nasopharyngeal Squamous Cell Carcinoma View
None Metastatic Oral Cavity Squamous Cell Carcinoma View
None Metastatic Oropharyngeal Squamous Cell Carcinoma View
None Metastatic Sinonasal Squamous Cell Carcinoma View
None Recurrent Head and Neck Squamous Cell Carcinoma View
None Recurrent Hypopharyngeal Squamous Cell Carcinoma View
None Recurrent Laryngeal Squamous Cell Carcinoma View
None Recurrent Nasopharyngeal Squamous Cell Carcinoma View
None Recurrent Oral Cavity Squamous Cell Carcinoma View
None Recurrent Oropharyngeal Squamous Cell Carcinoma View
None Recurrent Sinonasal Squamous Cell Carcinoma View
None Squamous Cell Carcinoma of Unknown Primary View
None Stage IV Cutaneous Squamous Cell Carcinoma of the Head and … View
None Stage IV Hypopharyngeal Carcinoma AJCC v8 View
None Stage IV Laryngeal Cancer AJCC v8 View
None Stage IV Lip and Oral Cavity Cancer AJCC v8 View
None Stage IV Nasopharyngeal Carcinoma AJCC v8 View
None Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 View
None Stage IV Sinonasal Cancer AJCC v8 View
Keywords: